Related Experiment Video
Updated: Nov 4, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Acute Peripheral Arterial Thrombosis in COVID-19 Patients on Therapeutic Anticoagulation
Abhyuday Kumar1, Neeraj Kumar2, Shettru K Arun1
1Department of Anaesthesiology, All India Institute of Medical Sciences, Patna, Bihar, India.
Insights
Severe COVID-19 can cause rare arterial clots even with anticoagulation. Prompt intervention like thrombectomy may be needed for limb-threatening arterial thrombosis in these patients.
Area of Science:
- Vascular Medicine
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease-2019 (COVID-19) is frequently associated with venous thromboembolism.
- Arterial thrombosis is an uncommon complication, particularly in patients receiving therapeutic anticoagulation.
Observation:
- Two cases of acute peripheral arterial thrombosis in patients with COVID-19 on therapeutic low-molecular-weight heparin are presented.
- One patient developed radial artery thrombosis affecting the hand, while the other experienced anterior tibial artery thrombosis leading to limb amputation.
Findings:
- Both patients demonstrated limited response to additional heparin infusion.
- These cases highlight the potential for severe arterial thrombosis despite standard anticoagulation therapy in COVID-19.
Implications:
- Consider intensified anticoagulation strategies for high-risk COVID-19 patients prone to venous thrombosis.
- Early consideration of interventional thrombectomy is crucial for managing arterial thrombosis unresponsive to pharmacological treatment.
Abstract:
Coronavirus disease-2019 (COVID-19) disease is often complicated by venous thrombosis and embolism. However, arterial thrombosis in a patient already on therapeutic anticoagulation is a rare occurrence. In one patient, we found thrombosis of the radial artery leading to ischemia of the fingers and lateral part of the palm. In another patient, thrombosis was found in the anterior tibial artery, resulting in ischemia of the limb and amputation. Both these patients were on a therapeutic dose of low-molecular-weight heparin. In both cases, heparin infusion was started but with little benefit. It is suggested that intensified anticoagulation should be done in patients at high-risk venous thrombosis, and prompt interventional thrombectomy should be done in cases of failure of pharmacological anticoagulation.
How To Cite This Article:
Kumar A, Kumar N, Arun SK, Ghosh S, Pattanayak A. Acute Peripheral Arterial Thrombosis in COVID-19 Patients on Therapeutic Anticoagulation. Indian J Crit Care Med 2021;25(4):461-462.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease I: Introduction
Peripheral Artery Disease IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins

